IP Library › Granted Patent US 7,705,128
Granted Patent B2
US 7,705,128 · App. 12/166,162 · Granted Apr 27, 2010

IL-1-like cytokine

Assignee: Schering Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,705,128
App. No.
12/166,162
Granted
Apr 27, 2010
Kind
B2
Abstract

Nucleic acids encoding mammalian, e.g., primate, IL-1ζ, purified IL-1ζ polypeptides and fragments thereof. Binding proteins, e.g., antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.

Claims (2)

1. An isolated or recombinant polypeptide comprising a sequence having 95% sequence identity with SEQ ID NO: 2.

2. The isolated or recombinant polypeptide of claim 1 comprising the sequence of SEQ ID NO: 2.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →
Continuity (5)
Division 1148331200 · Jul 7, 2006
Division 1069519500 · Oct 27, 2003
Division 0939841200 · Sep 17, 1999
Provisional Application 6010094800 · Sep 18, 1998
Related Publication 20080299139A1 · Dec 4, 2008